by Nicholas Malfitano for Forbes.com
December 6, 2016
The very day that a national report is issued naming the Philadelphia County Court of Common Pleas as a “Judicial Hellhole” where civil lawsuits are handled unfairly against businesses, the first win for plaintiffs in Xarelto litigation is secured with a near-$28 million verdict.
The verdict was rendered Tuesday in the first Xarelto bellwether case to reach a Pennsylvania state court, whose jury decided after almost one month of proceedings that warnings from manufacturers Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) and Bayer of the drug’s risks for internal bleeding were inadequate. Read more.